Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2000
12/07/2000WO2000073321A1 Human tumor necrosis factor receptor tr10
12/07/2000WO2000073319A1 Method for enhanced protein stabilization and production of cell lines useful for production of such stabilized proteins
12/07/2000WO2000073318A1 Methods of dna purification and purified dna
12/07/2000WO2000073316A2 Virus immunologic determinants
12/07/2000WO2000073263A1 Cytofectin dimers and methods of use thereof
12/07/2000WO2000072968A1 Multiple fluid sample processor and system
12/07/2000WO2000072887A1 A novel packaging cell line for the rescue, production and titration of high-capacity adenovirus amplicon vectors
12/07/2000WO2000072886A1 Episomally replicating lentiviral vectors
12/07/2000WO2000072885A2 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
12/07/2000WO2000072880A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072876A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072871A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
12/07/2000WO2000072869A1 Methods for producing 5'-nucleic acid-protein conjugates
12/07/2000WO2000072863A2 Uses of h-trek-1 polypeptides and polynucleotides encoding them
12/07/2000WO2000072742A2 Methods and materials for generating sh3 domains with tailored binding properties
12/07/2000WO2000072679A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
12/07/2000WO2000072670A1 Lkb1 gene knockout animals
12/07/2000WO2000072666A2 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE
12/07/2000WO2000072650A2 Compositions and methods for bioremediation
12/07/2000WO2000050565A3 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
12/07/2000WO2000049937A3 Trpm-2 antisense therapy
12/07/2000WO2000049151A3 POLYMORPHIC HUMAN GABAA RECEPTOR α-6 SUBUNIT
12/07/2000WO2000047740A3 Tnf-related proteins
12/07/2000WO2000047727A3 Nucleic acid molecules encoding alternansucrase
12/07/2000WO2000047724A3 Methods to mediate polyketide synthase module effectiveness
12/07/2000WO2000046391A3 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
12/07/2000WO2000045849A3 Use of cationic lipids to generate anti-tumor immunity
12/07/2000WO2000044940A3 Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
12/07/2000WO2000044392A3 Identification of specific differentially expressed mycobacterial antigens
12/07/2000WO2000043519A3 Neisseria meningitidis polypeptides
12/07/2000WO2000042561A3 Oligonucleotide mediated nucleic acid recombination
12/07/2000WO2000042205A3 Herbicide target gene and methods
12/07/2000WO2000039304A9 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
12/07/2000WO2000036407A9 Separation of charged particles by a spatially and temporally varying electric field
12/07/2000WO2000031247A3 Recombinant methods and materials for producing epothilone and epothilone derivatives
12/07/2000WO2000023578A3 Methods of suppressing flowering in transgenic plants
12/07/2000WO2000020589A9 PTANs: TESTIS SPECIFIC PROTEINS EXPRESSED IN PROSTATE CANCER
12/07/2000DE19925235A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy
12/07/2000DE19925199A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy
12/07/2000DE19925143A1 Neue liposomale Vektorkomplexe und deren Verwendung für die Gentherapie New liposomal vector complexes and their use for gene therapy
12/07/2000DE19925052A1 New recombinase-based protein complex for targeted transport of (poly)peptide or nucleic acid and sequence-specific integration of DNA vector, useful e.g. as antitumor agent
12/07/2000DE19924965A1 Preparing an agent for diagnosis or control of microbial infection, useful particularly against Helicobacter, based on identification of essential genes in defective mutants
12/07/2000CA2414214A1 Four-helical bundle protein zsig81
12/07/2000CA2383254A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/07/2000CA2383244A1 Protein kinases
12/07/2000CA2378737A1 Adipocyte complement related protein homolog zacrp5
12/07/2000CA2376133A1 Tumor-associated antigen (c42)
12/07/2000CA2376116A1 Promotion or inhibition of angiogenesis and cardiovascularization
12/07/2000CA2375888A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy
12/07/2000CA2375873A1 Methods and compositions for isolating high molecular weight dna from natural samples
12/07/2000CA2375855A1 Modulation of gene expression in gastrointestinal inflammation
12/07/2000CA2375802A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy
12/07/2000CA2375700A1 Polymer conjugates of hedgehog proteins and uses
12/07/2000CA2375349A1 A method for the transfer of antigens to dendritic cells
12/07/2000CA2375196A1 Use of gabapentin in assays to identify gabab receptor modulators
12/07/2000CA2375147A1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000CA2375128A1 A global regulator used to enhance the synthesis of aromatic substances
12/07/2000CA2375123A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
12/07/2000CA2375120A1 Bioactive sensors
12/07/2000CA2375119A1 Compositions and methods for production of recombinant virus using a carrier vector derived from a nonmammalian virus
12/07/2000CA2375106A1 Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
12/07/2000CA2375104A1 Prevention and treatment of amyloidogenic disease
12/07/2000CA2375095A1 Groel muteins with improved stability
12/07/2000CA2375084A1 Novel gbv sequence
12/07/2000CA2375071A1 Method for reducing phytate in canola meal using genetic manipulation involving myo-inositol 1-phosphate synthase gene
12/07/2000CA2375050A1 T-bet compositions and methods of use thereof
12/07/2000CA2375049A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
12/07/2000CA2375047A1 Dna encoding snorf33 receptor
12/07/2000CA2375033A1 Vaccines against conformation-dependent antigens and against antigens that are not or are not only proteins or peptides
12/07/2000CA2374990A1 C-cam as an angiogenesis inhibitor
12/07/2000CA2374928A1 Genetic assay system
12/07/2000CA2374908A1 Multiple fluid sample processor and system
12/07/2000CA2374878A1 Nucleic acid probes and methods for detecting clinically important fungal pathogens
12/07/2000CA2374612A1 Novel murine and human kinases
12/07/2000CA2374599A1 Dr4 antibodies and uses thereof
12/07/2000CA2374597A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders
12/07/2000CA2374433A1 Novel endo-beta-1,4-glucanases
12/07/2000CA2374412A1 Secreted alpha-helical protein-31
12/07/2000CA2374409A1 A variant of c6 .beta.-chemokine leukotactin-1(shlkn-1) with enhanced biological activity
12/07/2000CA2374402A1 Biosynthesis of foreign proteins using transformed microalgae
12/07/2000CA2374391A1 Mammalian receptor proteins; related reagents and methods
12/07/2000CA2374387A1 Adipocyte complement related protein homolog zacrp7
12/07/2000CA2374376A1 Lipid metabolism transcription factor
12/07/2000CA2374369A1 Assays for caspase activity using green fluorescent proteins
12/07/2000CA2374365A1 Gene switches
12/07/2000CA2374347A1 Screening method for peptides
12/07/2000CA2374222A1 Cytoskeleton-associated proteins
12/07/2000CA2374141A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
12/07/2000CA2374133A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000CA2373915A1 Methods and compositions for inhibiting neoplastic cell growth
12/07/2000CA2373726A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
12/07/2000CA2373638A1 Adam polynucleotides and polypeptides
12/07/2000CA2373547A1 Methods for induction of tolerance to adenoviral vectors and transgene products
12/07/2000CA2373047A1 Methods for producing 5'-nucleic acid-protein conjugates
12/07/2000CA2372566A1 Modified cytokine for its stabilisation
12/07/2000CA2372250A1 Fimbrial proteins
12/07/2000CA2372246A1 Human tumor necrosis factor receptor tr10
12/07/2000CA2372243A1 Method for enhanced protein stabilization and production of cell lines useful for production of such stabilized proteins
12/07/2000CA2372242A1 Virus immunologic determinants
12/07/2000CA2371995A1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
1 ... 3144 3145 3146 3147 3148 3149 3150 3151 3152 3153 3154 3155 3156 3157 3158 3159 3160 3161 3162 3163 3164 ... 4023